Journal List > J Korean Foot Ankle Soc > v.20(3) > 1043388

Chun, Jeon, Choi, Kim, Nho, and Won: The Amputation Rate and Associated Risk Factors within 1 Year after the Diagnosis of Diabetic Foot Ulcer

Abstract

Purpose:

This study investigates the amputation rate within 1 year after the diagnosis of diabetic foot ulcer and its associated risk factors.

Materials and Methods:

This study enrolled 60 patients with diabetic foot ulcer. The mean and standard deviation age was 64.4±12.8 years (range, 32∼89 years); the mean and standard deviation prevalence period for diabetes mellitus was 21.0±7.5 years (range, 0.5∼36 years). The amputation rate was evaluated by dividing the subjects into two groups—the major and minor amputation groups—within 1 year following the initial diagnosis of diabetic foot ulcer. Multivariate Cox proportional hazards regression analysis was used to identify the risk factors for amputation.

Results:

The total amputation rate of 38.3% (n=23) was comprised of the amputation rate for the major amputation group (10.0%) and rate for the minor amputation group (23.8%). There was a high correlation between peripheral artery disease (toe brachial pressure index <0.7) and amputation (hazard ratio [HR] 5.81, confidence interval [CI] 2.09∼16.1, p<0.01). Nephropathy was significantly correlated with the amputation rate (HR 3.53, CI 1.29∼9.64, p=0.01).

Conclusion:

Clinicians who treat patients with diabetic foot complications must understand the fact that the amputation rate within 1 year is significant, and that the amputation rate of patients with peripheral artery disease or nephropathy is especially high.

REFERENCES

1.Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013. 97:775–90.
crossref
2.Singh N., Armstrong DG., Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005. 293:217–28.
crossref
3.Stiegler H. Das diabetische Fußsyndrom [Diabetic foot syndrome]. Herz. 2004. 29:104–15. German.
4.Gregg EW., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt MS., Wolz M, et al. Prevalence of lower-extremity disease in the US adult population >=42 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004. 27:1591–7.
5.Winkley K., Stahl D., Chalder T., Edmonds ME., Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications. 2007. 21:341–9.
crossref
6.Morbach S., Furchert H., Gröblinghoff U., Hoffmeier H., Kersten K., Klauke GT, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a de-cade. Diabetes Care. 2012. 35:2021–7.
crossref
7.Won SH., Chung CY., Park MS., Lee T., Sung KH., Lee SY, et al. Risk factors associated with amputation-free survival in patient with diabetic foot ulcers. Yonsei Med J. 2014. 55:1373–8.
crossref
8.Faglia E., Clerici G., Caminiti M., Curci V., Somalvico F. Prognostic difference between soft tissue abscess and osteomyelitis of the foot in patients with diabetes: data from a consecutive series of 452 hospitalized patients. J Foot Ankle Surg. 2012. 51:34–8.
crossref
9.Beks PJ., Mackaay AJ., de Neeling JN., de Vries H., Bouter LM., Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995. 38:86–96.
crossref
10.Høyer C., Sandermann J., Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg. 2013. 58:231–8.
crossref
11.Sharp CS., Bessman AN., Wagner FW Jr., Garland D. Microbiology of deep tissue in diabetic gangrene. Diabetes Care. 1978. 1:289–92.
crossref
12.Pscherer S., Dippel FW., Lauterbach S., Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012. 6:241–6.
crossref
13.Miyajima S., Shirai A., Yamamoto S., Okada N., Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract. 2006. 71:272–9.
crossref
14.Kaminski M., Frescos N., Tucker S. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on hae-modialysis. Intern Med J1. 2012. 42:e120–8.
crossref

Fig. 1.
Kaplan-Meier curves depending on toe-brachial pressure index (log-rank test p<0.01). TBPI: toe-brachial pressure index.
jkfas-20-121f1.tif
Fig. 2.
Kaplan-Meier curves depending on nephropathy (log-rank test p<0.01).
jkfas-20-121f2.tif
Table 1.
Demographic and Clinical Patient Characteristics
Characteristic Value
Mean age (yr) 64.4±12.8
Sex
Male 34 (56.7)
Female 26 (43.3)
Type of diabetes
Type 1 4 (6.7)
Type 2 56 (93.3)
Treatment
Insulin 29 (48.3)
Tablet 31 (51.7)
Current smoking status
Non- or ex-smoker 34 (56.7)
Smoker 26 (43.3)
Mean duration of diabetes (yr) 21.0±7.5
Mean glycosylated hemoglobin level (%) 7.3±1.2
Wagner classification
Grade 1 26 (43.3)
Grade 2 9 (15.0)
Grade 3 15 (25.0)
Grade 4 10 (16.7)
Grade 5 0
Duration of ulcer (mo) 4.1±2.3
ABPI
≥0.9 39 (65.0)
<0.9 21 (35.0)
TBPI
≥0.7 40 (66.7)
<0.7 20 (33.3)
Complication
Macrovascular 14 (23.3)
Microvascular 21 (35.0)
Nephropathy 24 (40.0)
Neuropathy 46 (76.7)
Cerebrovascular 10 (16.7)
Amputation
Major (above the ankle) 6 (10.0)
Minor (below the ankle) 17 (28.3)

Values are presented as mean±standard deviation or number (%). ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

Table 2.
Univariate Cox Proportional Hazards Regression Models
Explanatory variable All amputation (n=23) Major amputation (n=6) Minor amputation (n=17)
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Age 1.01 (0.98∼1.05) 0.31 1.05 (0.98∼1.12) 0.15 1.00 (0.97∼1.03) 0.87
Sex (male vs female) 1.67 (0.71∼3.89) 0.23 0.50 (0.16∼1.59) 0.24 1.98 (0.89∼4.44) 0.09
Duration of diabetes 1.03 (0.97∼1.09) 0.33 0.98 (0.93∼1.04) 0.5 0.99 (0.96∼1.02) 0.66
Smoking (current smoker) 1.07 (0.59∼1.97) 0.82 0.03 (0.00∼13.17) 0.28 1.29 (0.69∼2.42) 0.43
ABPI (<0.9) 5.83 (2.27∼14.9) <0.01 11.11 (1.29∼96.17) 0.02 4.79 (1.66∼13.8) <0.01
TBPI (<0.7) 7.64 (2.81∼20.7) <0.01 8.12 (0.96∼52.3) 0.05 5.03 (1.74∼14.5) <0.01
Severity of ulcer 4.12 (1.61∼10.5) <0.01 8.07 (0.94∼68.9) 0.05 3.35 (1.16∼9.65) 0.02
Duration of ulcer 1.18 (0.99∼1.40) 0.76 1.00 (0.93∼1.09) 0.89 0.99 (0.94∼1.05) 0.72
HbA1c (>7.5%) 1.06 (0.52∼2.14) 0.87 1.01 (0.32∼3.22) 0.99 0.50 (0.26∼0.95) 0.08
Macrovascular 2.04 (0.78∼5.32) 0.14 2.04 (0.55∼7.59) 0.29 1.10 (0.62∼1.97) 0.74
Microvascular 1.13 (0.46∼2.76) 0.77 0.91 (0.29∼2.89) 0.88 0.67 (0.36∼1.26) 0.22
Nephropathy 5.19 (1.99∼13.5) <0.01 10.03 (1.17∼86.5) 0.03 4.19 (1.41∼12.47) 0.01
Neuropathy 0.41 (0.14∼1.18) 0.10 24.8 (0.01∼81893.46) 0.44 1.13 (0.44∼2.89) 0.81
Cerebrovascular 1.53 (0.50∼4.60) 0.45 1.16 (0.31∼4.29) 0.83 0.60 (0.27∼1.36) 0.22

HR: hazard ratio, CI: confidence interval, ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

Table 3.
Multivariate Cox Proportional Hazards Regression Models
Explanatory variable All amputation (n=23) Major amputation (n=6) Minor amputation (n=17)
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
ABPI (<0.9) 1.46 (0.27∼7.78) 0.66 1.05 (0.06∼12.3) 0.65 2.02 (0.25∼16.6) 0.51
TBPI (<0.7) 5.81 (2.09∼16.1) <0.01 5.97 (1.52∼14.9) 0.02 4.07 (1.39∼11.9) 0.01
Severity of ulcer 0.72 (0.17∼2.99) 0.65 0.56 (0.08∼6.36) 0.73 0.84 (0.16∼4.36) 0.83
Nephropathy 3.53 (1.29∼9.64) 0.01 4.23 (1.04∼10.0) 0.04 3.23 (1.04∼10.0) 0.04

HR: hazard ratio, CI: confidence interval, ABPI: ankle brachial pressure index, TBPI: toe-brachial pressure index.

TOOLS
Similar articles